Indoco Remedies is currently trading at Rs. 161.25, up by 7.25 points or 4.71% from its previous closing of Rs. 154.00 on the BSE.
The scrip opened at Rs. 157.95 and has touched a high and low of Rs. 178.05 and Rs. 155.60 respectively. So far 61437 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 238.00 on 26-Nov-2018 and a 52 week low of Rs. 133.10 on 11-Oct-2019.
Last one week high and low of the scrip stood at Rs. 178.05 and Rs. 148.20 respectively. The current market cap of the company is Rs. 1531.54 crore.
The promoters holding in the company stood at 58.69%, while Institutions and Non-Institutions held 16.85% and 24.46% respectively.
Indoco Remedies has reported a net profit of Rs 7.33 crore for the quarter ended September 30, 2019 as against net loss of Rs 7.79 crore for the same quarter in the previous year. Total income of the company increased by 23.98% at Rs 292.55 crore for Q2FY20 as compared Rs 235.96 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a net profit of Rs 7.81 crore for the quarter under review as against net loss of Rs 7.45 crore for the same quarter in the previous year. Total income of the company increased by 24.05% at Rs 293.15 crore for Q2FY20 as compared Rs 236.31 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1504.25 |
Dr. Reddys Lab | 6263.70 |
Cipla | 1406.25 |
Zydus Lifesciences | 948.20 |
Lupin | 1615.85 |
View more.. |